School of Medicine

WashU Medicine researchers found that dozens of blood proteins shifted during treatment with the anti-amyloid medication lecanemab, which could enable future blood tests monitoring a person’s response to the drug.

WashU Medicine allergist and immunologist Maya Jerath, MD, PhD, has treated over 650 patients with alpha-gal, a potentially life-threatening allergic reaction triggered by tick bites — and the prevalence is increasing rapidly, she says.

A new Transcend Initiative seeks to address and fight life-threatening mycobacterial infections.

WashU Medicine researchers found that bacteria-infecting viruses and bacterial antibiotic resistance genes in the gut microbiomes of premature babies play an important role in necrotizing enterocolitis, a sudden and often fatal intestinal illness.

David M. Holtzman, MD, of WashU Medicine, was recognized by the National Institute of Neurological Disorders and Stroke for impactful mentorship of future scientists.

WashU Medicine researcher Makedonka Mitreva was honored with the Ward Medal from the American Society of Parasitologists for her use of genetics and genomics to understand parasitic worms.

WashU Medicine researchers have uncovered new insights into the pharmacology of ketamine that help explain both its rapid benefits and its risks.

Six WashU Medicine nurses were recognized with 2026 Excellence in Nursing awards from St. Louis Magazine, and an additional 12 were selected as finalists.

A clinical trial led by WashU Medicine researchers found that combining mental health coaching with medication optimization reduced post-surgery anxiety and depression in older adults.

Three-time WashU alumnus S. Hassan A. Akbari credits the connections he maintained with mentors for shaping his career in medicine.